Vaccine Blukoat Insulated Transport Articles & Analysis
1 news found
The Jenner Institute at Oxford University, together with partners Imaxio and GSK, has started a phase I clinical trial of a novel vaccine candidate aimed at blocking transmission of malaria. Around half the world’s population is at risk of malaria and the disease led to an estimated 584,000 deaths in 2013. MosquirixTM, a malaria vaccine candidate developed by GSK, has just received a ...